Adverse reactions to trimethoprim/sulfamethoxazole for melioidosis eradication therapy: An evaluation of frequency and risk factors

MLA

Genevieve E. Martin, et al. “Adverse Reactions to Trimethoprim/Sulfamethoxazole for Melioidosis Eradication Therapy: An Evaluation of Frequency and Risk Factors.” International Journal of Infectious Diseases, vol. 150, no. 107283-, Jan. 2025. EBSCOhost, https://doi.org/10.1016/j.ijid.2024.107283.

APA

Genevieve E. Martin, Joshua Bramwell, Eden Gadil, Celeste Woerle, Thomas Ewin, Jane Davies, Sonja Janson, & Bart J. Currie. (2025). Adverse reactions to trimethoprim/sulfamethoxazole for melioidosis eradication therapy: An evaluation of frequency and risk factors. International Journal of Infectious Diseases, 150(107283-). https://doi.org/10.1016/j.ijid.2024.107283

Chicago

Genevieve E. Martin, Joshua Bramwell, Eden Gadil, Celeste Woerle, Thomas Ewin, Jane Davies, Sonja Janson, and Bart J. Currie. 2025. “Adverse Reactions to Trimethoprim/Sulfamethoxazole for Melioidosis Eradication Therapy: An Evaluation of Frequency and Risk Factors.” International Journal of Infectious Diseases 150 (107283-). doi:10.1016/j.ijid.2024.107283.